APEIRON Capital’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-130,600
Closed -$17.4M – 8
2026
Q2
$17.4M Buy
+130,600
New +$14.8M 11.18% 3

Other funds holding ABVX

APEIRON Capital's ABVX Position: Q3 2026 in Review

APEIRON Capital sold out of Abivax (ABVX) in Q3 2026, closing a stake of 130,600 shares — an estimated $17.4M sold.

APEIRON Capital first reported a position in ABVX in Q2 2026 and held it in 1 quarter. The position peaked at $17.4M in Q2 2026. 211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • APEIRON Capital reported no remaining Abivax position as of Q3 2026 after selling out during the quarter.
  • APEIRON Capital sold 130,600 Abivax shares in Q3 2026, an estimated $17.4M.
  • APEIRON Capital first reported a position in Abivax in Q2 2026 and held it in 1 quarter.
  • APEIRON Capital's Abivax position peaked at $17.4M in Q2 2026.
  • 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on APEIRON Capital's 13F filing for Q3 2026, filed 4 Nov 2026.